TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ELTX

Elicio Therapeutics Inc.

Healthcare · Biotechnology

1.90$ +0.0% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow ELTX
Line item 2012 2013 2018 2019 2020 2021 2022 2023 2024 2025
14.6% 28.8% -199.1% -1,653.6% -794.7% -84.6%
6.3% 7.0% 0.0% 33.4% 21.8% 0.9%
9.8% 10.6% 2.2%
11.1% 12.3% 4.7%
-1.0% 5.1% 76.6% 655.7% 894.8% 3.1%
0.7% 0.3% 0.0% 16.3% 1.4% 1.9%
-0.7% -1.0% -16.3% -1.4% -1.9%
-25.2% -1.3%
987.3% 509.7% 51.9%
-5.9% -17.8% 787.8% 328.9% 1,819.8% 68.5%
8.1% 9.9% 582.1% -1,341.0% 1,008.2% -17.9%
13.9% 28.5% -199.1% -1,669.9% -796.1% -86.4%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?